文献速递内脏/肾动脉与血管畸形

血管内血运重建与开放手术血运重建作为动脉性急性肠系膜缺血首选策略的系统评价与Meta分析

Endovascular revascularization vs open surgical revascularization as the first strategy for arterial acute mesenteric ischemia: A systematic review and meta-analysis.
PubMed 文献 · J Vasc Surg · 2024-07-26

该系统评价与Meta分析纳入11项研究共1141例动脉性急性肠系膜缺血患者,比较血管内血运重建(EVR)与开放手术血运重建(OSR)作为首选策略的死亡与并发症。EVR可能不降低短期死亡率(OR 0.79,95%CI 0.50-1.25,P=.31)及二次探查剖腹术(OR 1.00,95%CI 0.30-3.36,P=.99),但可能与肠切除(OR 0.42,95%CI 0.20-0.88,P=.022)及短肠综合征(OR 0.39,95%CI 0.21-0.75,P=.005)减少相关,证据确定性均极低。

要点

  • EVR作为动脉性AMI首选策略可能不降低短期死亡率(OR 0.79,95%CI 0.50-1.25,P=.31,证据确定性极低)。
  • EVR可能与肠切除减少相关(OR 0.42,95%CI 0.20-0.88,P=.022,证据确定性极低)。
  • EVR可能与短肠综合征减少相关(OR 0.39,95%CI 0.21-0.75,P=.005,证据确定性极低)。

核心结论

  • 与OSR相比,EVR作为动脉性AMI的首选治疗可能不降低短期死亡率或二次探查剖腹术。
  • EVR可能与肠切除及短肠综合征减少相关。
  • 亟需未来的多中心随机对照试验来证实这些结果。

研究设计与样本

  • 系统评价与配对Meta分析,按照PRISMA声明执行。
  • 检索PubMed、Embase和Cochrane Library数据库,从建库至2023年12月31日,限制英文语言,最终检索日期为2024年1月2日。
  • 共纳入11项比较EVR与OSR用于动脉性AMI的研究,合计1141例患者。
  • 患者平均年龄61.9至73.6岁,45.1%为男性。
  • 主要结局为短期死亡率;次要结局包括肠切除、二次探查剖腹术和短肠综合征。

主要发现

  • 与OSR相比,EVR作为首选治疗可能不降低短期死亡率(OR 0.79,95%CI 0.50-1.25,P=.31,证据确定性极低)。
  • 与OSR相比,EVR的二次探查剖腹术无显著差异(OR 1.00,95%CI 0.30-3.36,P=.99,证据确定性极低)。
  • 与OSR相比,EVR可能与肠切除减少相关(OR 0.42,95%CI 0.20-0.88,P=.022,证据确定性极低)。
  • 与OSR相比,EVR可能与短肠综合征减少相关(OR 0.39,95%CI 0.21-0.75,P=.005,证据确定性极低)。
  • Meta回归显示,EVR与OSR的死亡率未受血栓性病因显著影响(-0.002,95%CI -0.027至0.022,P=.85),但受发表年份显著影响(0.076,95%CI 0.069-0.145,P=.031)。

关键数值与推荐

  • 主要结局短期死亡率:EVR vs OSR的OR 0.79(95%CI 0.50-1.25,P=.31,证据确定性极低)。
  • 二次探查剖腹术:EVR vs OSR的OR 1.00(95%CI 0.30-3.36,P=.99,证据确定性极低)。
  • 肠切除:EVR vs OSR的OR 0.42(95%CI 0.20-0.88,P=.022,证据确定性极低)。
  • 短肠综合征:EVR vs OSR的OR 0.39(95%CI 0.21-0.75,P=.005,证据确定性极低)。
  • Meta回归:血栓性病因对死亡率影响的系数-0.002(95%CI -0.027至0.022,P=.85),发表年份系数0.076(95%CI 0.069-0.145,P=.031)。

临床怎么用

  • 作者认为,与OSR相比,EVR作为动脉性AMI的首选治疗可能不降低短期死亡率或二次探查剖腹术。
  • 作者认为,EVR可能与肠切除及短肠综合征减少相关。
  • 作者建议,亟需未来的多中心随机对照试验来证实这些结果。

局限性

  • 所有结局的证据确定性均为极低(very low certainty)。
  • 作者指出亟需未来的多中心随机对照试验来证实这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This paired meta-analysis aimed to compare the mortality and morbidity of endovascular revascularization (EVR) and open surgical revascularization (OSR) as the first strategy for arterial acute mesenteric ischemia (AMI). METHODS: This systematic review and meta-analysis were performed in accordance with the PRISMA statement. A systematic search strategy was performed to identify eligible studies using the following databases: PubMed, Embase, and Cochrane Library database from inception to December 31, 2023, with restriction to the English language. The end search date was January 2, 2024. The primary outcome was short-term mortality. Secondary outcomes included bowel resection, second-look laparotomy, and short bowel syndrome. The counterenhanced funnel plot and the Peters' test were used to assess bias. Outcomes were reported as odds ratio (OR) with a 95% confidence interval (CI) using the Mantel-Haenszel method. The GRADE classification was used to estimate the certainty of evidence. RESULTS: A total of 11 studies (1141 patients) comparing EVR vs OSR for arterial AMI were identified and analyzed. The mean patient age was 61.9 to 73.6 years and 45.1% of the patients were male. Compared with OSR, EVR as the first treatment may not decrease short-term mortality (OR, 0.79; 95% CI, 0.50-1.25; P = .31; very low certainty) and second-look laparotomy (OR, 1.00; 95% CI, 0.30-3.36; P = .99; very low certainty). However, EVR may be associated with decreased bowel resection (OR, 0.42; 95% CI, 0.20-0.88; P = .022; very low certainty) and short bowel syndrome (OR, 0.39; 95% CI, 0.21-0.75; P = .005; very low certainty). The metaregression revealed that the mortality regarding EVR vs OSR was not impacted significantly by thrombotic etiology (-0.002; 95% CI, -0.027 to 0.022; P = .85), whereas it was impacted significantly by publication year (0.076; 95% CI, 0.069-0.145; P = .031). CONCLUSIONS: Compared with OSR, EVR as the first treatment for arterial AMI may not decrease short-term mortality or second-look laparotomy. Future multicenter randomized controlled trials are needed urgently to confirm these results.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Shi Y, Zhao B, Zhou Y, et al. Endovascular revascularization vs open surgical revascularization as the first strategy for arterial acute mesenteric ischemia: A systematic review and meta-analysis. J Vasc Surg. 2024. PMID: 39069018. doi:10.1016/j.jvs.2024.07.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。